*By Carlo Versano*
A new start-up wants to help patients and caregivers with the age-old problem of managing medications for chronic or serious illnesses.
Hero sprang from the mind of Kal Vepuri, whose aptly-named Brainchild Holdings led a $12 million investment round for the company, which produces an eponymous counter-top device that can store and dispense pills in pre-selected dosages at certain times.
Vepuri told Cheddar he came up with the idea after he became a caregiver for his ill mother.
"She took almost a dozen medications at one point," he said, and the task of organizing, remembering, and dispensing them, as well as dealing with multiple prescribing physicians and changing dosages became an overwhelming task.
So Vepuri took his experience as an entrepreneur and tech consultant to build Hero, which resembles a kitchen appliance married to an Apple device.
The problems surrounding medication management are what he called a "phantom issue" ー no one wants to talk about it, but a stunning number of people have to deal with it ー 70 million Americans have multiple chronic diseases, Vepuri said, and that number will unfortunately only go up as Baby Boomers age, and more millennials are tasked with taking care of their older parents (one-fourth of caregivers are already millennials).
"It's not really great dinner table conversation," he said, "But when you're one-on-one with somebody, and they bring up a problem that they've faced themselves and has been so personal to them and their family, they tend to understand it immediately."
The Hero device can't tell if a user has actually taken his or her pills, but it can remind that person (or a family member or caregiver) through an app notification.
Vepuri said he plans to use the new funding to educate consumers and develop partnerships and online direct-to-caregiver systems so that Hero can be a closed-loop solution for caregivers and patients alike.
For full interview [click here](https://cheddar.com/videos/healthcare-start-up-hero-launches-with-12-million-seed-funding).
Wealthfront’s CFO Alan Iberman talks the $2.05B IPO and the major moment for robo banking as the company bets on AI, automation, and “self-driving money."
A rare magnum of Dom Pérignon Vintage 1961 champagne that was specially produced for the 1981 wedding of Prince Charles and Lady Diana has failed to sell during an auction. Danish auction house Bruun Rasmussen handled the bidding Thursday. The auction's house website lists the bottle as not sold. It was expected to fetch up to around $93,000. It is one of 12 bottles made to celebrate the royal wedding. Little was revealed about the seller. The auction house says the bids did not receive the desired minimum price.
The New York Times and President Donald Trump are fighting again. The news outlet said Wednesday it won't be deterred by Trump's “false and inflammatory language” from writing about the 79-year-old president's health. The Times has done a handful of stories on that topic recently, including an opinion column that said Trump is “starting to give President Joe Biden vibes.” In a Truth Social post, Trump said it might be treasonous for outlets like the Times to do “FAKE” reports about his health and "we should do something about it.” The Republican president already has a pending lawsuit against the newspaper for its past reports on his finances.
OpenAI has appointed Slack CEO Denise Dresser as its first chief of revenue. Dresser will oversee global revenue strategy and help businesses integrate AI into daily operations. OpenAI CEO Sam Altman recently emphasized improving ChatGPT, which now has over 800 million weekly users. Despite its success, OpenAI faces competition from companies like Google and concerns about profitability. The company earns money from premium ChatGPT subscriptions but hasn't ventured into advertising. Altman had recently announced delays in developing new products like AI agents and a personal assistant.
President Donald Trump says he will allow Nvidia to sell its H200 computer chip used in the development of artificial intelligence to “approved customers” in China. Trump said Monday on his social media site that he had informed China’s leader Xi Jinping and “President Xi responded positively!” There had been concerns about allowing advanced computer chips into China as it could help them to compete against the U.S. in building out AI capabilities. But there has also been a desire to develop the AI ecosystem with American companies such as chipmaker Nvidia.
